Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Alexander van Rosendael , Dipti Itchhaporia Added: 1 year ago
In this episode of the "Innovations in Cardiology" series, host Dr Dipti Itchhaporia (Hoag Heart and Vascular Institute, Newport Beach, CA, US) is joined by Dr Alexander Van Rosendael (Leiden University Medical Center, Leiden, NL) to discuss the findings from the CONFIRM2 trial. Conducted from up to 50 international clinical CCTA sites with 35,000 patients, CONFIRM2 aims to improve comprehensive… View more
Added: 6 months ago Source:  Radcliffe Cardiology
A study has found that while the severity of ischaemia correlates poorly with daily angina symptoms in patients with stable coronary artery disease (CAD), the development of coronary collateral circulation is associated with both the ischaemic burden and reduced intensity of ischaemic chest pain.¹ This may help explain the often-observed disconnect between stenosis severity and patient-reported… View more
Author(s): Tatsuya Nakama Added: 1 year ago
LINC 2025 - Outcomes from the GRIFFIN study suggest post-procedural functional flow reserve (FFR) could be a useful predictor of restenosis after drug-coated balloon (DCB) angioplasty for superficial femoral artery (SFA) lesions. Restenosis patients showed significantly lower FFR values than non-restenosis patients, and the study resulted in a good FFR cut-off value of restenosis after DCB… View more
Added: 10 months ago Source:  Radcliffe Cardiology
AUTHOR: Ola WisniewskaA novel optical coherence tomography (OCT)-based physiological assessment, virtual flow reserve (VFR), has been shown to predict 2-year clinical outcomes following percutaneous coronary intervention (PCI), independent of anatomical measures like minimal stent area (MSA). This finding comes from a new substudy of the ILUMIEN IV trial, highlighting the potential of VFR to… View more
Author(s): Joost Daemen Added: 2 months ago
American College of Cardiology Congress 2026 - Dr Joost Daemen (Thoraxcenter, Erasmus University Medical Center, Rotterdam, NL) joins us to discuss findings from the FAST III trial (NCT04931771; ECRI) a large-scale randomised study comparing fractional flow reserve (FFR) with 3D-quantitative coronary angiography-derived vessel FFR (vFFR) to guide coronary revascularisation.This randomised, open… View more